AN2 Therapeutics, Inc. (ANTX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.94M | -6.6% |
| 2024 | $21.35M | +36.5% |
| 2023 | $15.65M | -42.5% |
| 2022 | $27.22M | +125.0% |
| 2021 | $12.10M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $19.94M | -6.6% |
| 2024 | $21.35M | +36.5% |
| 2023 | $15.65M | -42.5% |
| 2022 | $27.22M | +125.0% |
| 2021 | $12.10M | — |